How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes

Paul Ward, Oncology MSLs, AstraZeneca, MSL Society, Covid-19 impact on MSLs

My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success. In this epi…

May 12^th • 41 mins listen

How Information is Consumed

Medical Science Liaisons, Andrew Fariello, AstraZeneca, data sharing, technological advancements

In this episode, Tom Caravela is joined by Andrew Fariello from AstraZeneca to explore the evolving landscape of Medical Science Liaisons (MSLs) in the context of data sharing and technological advancements. Andrew shares his career journey and insights into the growing importance of surv…

Aug 29^th • 33 mins listen

Address Knowledge Gaps in Evidence-Based Precision Medicine Care

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss knowledge gaps in clinical practic…

Mar 29^th • 40 mins listen

Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care

ONS members Kristin Daly, MSN, ANP-BC, AOCNP®, medical oncology nurse practitioner at the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, MO, and Jessica Pforr, RN, AOCNP®, nurse practitioner at Mon Medical Center in Morgantown, WV, join Stephanie Jardine,…

Mar 29^th • 38 mins listen